“…A difference in accomplishing vaginal deliveries between the two groups was hypothesized because of the following previous findings associated with the use of ketanserin: fewer maternal complications [2], the absence of adverse effects on fetal heart rate tracings, [4,12] and the potentially lower incidence of hypotensive overshoot [1]. The absolute number of vaginal deliveries between the two treatment groups is not significantly different.…”
Ketanserin appears to be a better option than dihydralazine for treatment of severe preeclampsia since fewer maternal complications and side-effects were observed in patients receiving ketanserin.
“…A difference in accomplishing vaginal deliveries between the two groups was hypothesized because of the following previous findings associated with the use of ketanserin: fewer maternal complications [2], the absence of adverse effects on fetal heart rate tracings, [4,12] and the potentially lower incidence of hypotensive overshoot [1]. The absolute number of vaginal deliveries between the two treatment groups is not significantly different.…”
Ketanserin appears to be a better option than dihydralazine for treatment of severe preeclampsia since fewer maternal complications and side-effects were observed in patients receiving ketanserin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.